Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-13

Clinical Trial Update: A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial investigating different doses of sprifermin for safety and effectiveness in knee osteoarthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sprifermin (sprifermin)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2020-07-13